Sabra Healthcare REIT (SBC) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SBC Analyst Ratings

Moderate Buy

3 Buy

5 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Sabra

Healthcare REIT

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SBC Stock 12 Month Forecast

Average Price Target

€17.98

▲(6.12% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is €17.98 with a high forecast of €19.42 and a low forecast of €16.89. The average price target represents a 6.12% change from the last price of €16.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"€13","20":"€20","14.75":"€14.75","16.5":"€16.5","18.25":"€18.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.42004977,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€19.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.9762112871,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€17.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.8869998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€16.89</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,14.75,16.5,18.25,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.219,15.542157674615384,15.865315349230768,16.188473023846154,16.511630698461538,16.834788373076922,17.157946047692306,17.48110372230769,17.804261396923074,18.127419071538462,18.450576746153846,18.77373442076923,19.096892095384614,{"y":19.42004977,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.219,15.43109317593077,15.643186351861537,15.855279527792307,16.067372703723077,16.279465879653845,16.491559055584617,16.703652231515385,16.915745407446153,17.127838583376924,17.339931759307692,17.55202493523846,17.764118111169232,{"y":17.9762112871,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.219,15.347307676923077,15.475615353846154,15.60392303076923,15.732230707692308,15.860538384615385,15.988846061538462,16.11715373846154,16.245461415384618,16.373769092307693,16.50207676923077,16.630384446153847,16.758692123076926,{"y":16.8869998,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.655,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.583,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.915,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.181,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.386,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.796,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.691,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.124,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.49,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.282,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.578,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.219,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€19.42

Average Price Target€17.98

Lowest Price Target€16.89

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Anderson

Cantor Fitzgerald

€16.89→€17.73

Hold

4.67%

Upside

Reiterated

02/17/26

Sabra Health Care price target raised to $21 from $20 at Cantor FitzgeraldSabra Health Care price target raised to $21 from $20 at Cantor Fitzgerald

Farrell Granath

Bank of America Securities

€19.42

Buy

14.64%

Upside

Reiterated

02/17/26

Analysts Offer Insights on Real Estate Companies: Sabra Healthcare REIT (NASDAQ: SBRA), Essential Properties Realty (NYSE: EPRT) and American Tower (NYSE: AMT)

Michael Lewis

Truist Financial

Hold

―

Reiterated

02/13/26

Analysts Are Neutral on Top Real Estate Stocks: Sabra Healthcare REIT (SBRA), Public Storage (PSA)

Juan C. Sanabria

BMO Capital

€18.58

Hold

9.66%

Upside

Reiterated

02/13/26

Sabra Healthcare REIT: Solid SHOP Momentum Offset by Soft FFO Outlook and RCA Loan Uncertainty Supports Hold Rating

Nicholas Yulico

Scotiabank

€16.89

Hold

-0.31%

Downside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Real Estate Companies: Federal Realty (NYSE: FRT) and Sabra Healthcare REIT (NASDAQ: SBRA)

Michael Goldsmith

UBS

€16.89

Hold

-0.31%

Downside

Reiterated

01/08/26

UBS Remains a Hold on Sabra Healthcare REIT (SBRA)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€18.58

Buy

9.66%

Upside

Reiterated

12/15/25

Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)

John Kilichowski

Wells Fargo

€16.89→€17.73

Buy

4.67%

Upside

Reiterated

11/25/25

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Dave Rodgers

Robert W. Baird

€15.2→€16.89

Hold

-0.31%

Downside

Reiterated

08/29/25

Robert W. Baird Keeps Their Hold Rating on Sabra Healthcare REIT (SBRA)

Aaron Hecht

Citizens JMP

€16.89→€18.58

Buy

9.66%

Upside

Reiterated

08/06/25

Sabra Health Care price target raised to $22 from $20 at Citizens JMPSabra Health Care price target raised to $22 from $20 at Citizens JMP

Austin Wurschmidt

KeyBanc

Hold

―

Reiterated

02/25/25

KeyBanc Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Anderson

Cantor Fitzgerald

€16.89→€17.73

Hold

4.67%

Upside

Reiterated

02/17/26

Sabra Health Care price target raised to $21 from $20 at Cantor FitzgeraldSabra Health Care price target raised to $21 from $20 at Cantor Fitzgerald

Farrell Granath

Bank of America Securities

€19.42

Buy

14.64%

Upside

Reiterated

02/17/26

Analysts Offer Insights on Real Estate Companies: Sabra Healthcare REIT (NASDAQ: SBRA), Essential Properties Realty (NYSE: EPRT) and American Tower (NYSE: AMT)

Michael Lewis

Truist Financial

Hold

―

Reiterated

02/13/26

Analysts Are Neutral on Top Real Estate Stocks: Sabra Healthcare REIT (SBRA), Public Storage (PSA)

Juan C. Sanabria

BMO Capital

€18.58

Hold

9.66%

Upside

Reiterated

02/13/26

Sabra Healthcare REIT: Solid SHOP Momentum Offset by Soft FFO Outlook and RCA Loan Uncertainty Supports Hold Rating

Nicholas Yulico

Scotiabank

€16.89

Hold

-0.31%

Downside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Real Estate Companies: Federal Realty (NYSE: FRT) and Sabra Healthcare REIT (NASDAQ: SBRA)

Michael Goldsmith

UBS

€16.89

Hold

-0.31%

Downside

Reiterated

01/08/26

UBS Remains a Hold on Sabra Healthcare REIT (SBRA)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€18.58

Buy

9.66%

Upside

Reiterated

12/15/25

Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)

John Kilichowski

Wells Fargo

€16.89→€17.73

Buy

4.67%

Upside

Reiterated

11/25/25

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Dave Rodgers

Robert W. Baird

€15.2→€16.89

Hold

-0.31%

Downside

Reiterated

08/29/25

Robert W. Baird Keeps Their Hold Rating on Sabra Healthcare REIT (SBRA)

Aaron Hecht

Citizens JMP

€16.89→€18.58

Buy

9.66%

Upside

Reiterated

08/06/25

Sabra Health Care price target raised to $22 from $20 at Citizens JMPSabra Health Care price target raised to $22 from $20 at Citizens JMP

Austin Wurschmidt

KeyBanc

Hold

―

Reiterated

02/25/25

KeyBanc Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Stocks with the Highest Top Analyst Consensus in the Real Estate Sector

xxx

Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sabra Healthcare REIT

3 Months

xxx

Success Rate

4/9 ratings generated profit

Average Return

+3.01%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +3.01% per trade.

1 Year

Aaron HechtCitizens JMP

Success Rate

6/9 ratings generated profit

Average Return

+4.09%

reiterated a buy rating 7 months ago

Copying Aaron Hecht's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.09% per trade.

2 Years

xxx

Success Rate

6/9 ratings generated profit

Average Return

+3.46%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +3.46% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SBC Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SBC has received 13 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. SBC average Analyst price target in the past 3 months is 17.98.

Each month's total comprises the sum of three months' worth of ratings.

SBC Financial Forecast

SBC Earnings Forecast

Next quarter’s earnings estimate for SBC is €0.14 with a range of €0.14 to €0.15. The previous quarter’s EPS was €0.09. SBC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year SBC has Performed in-line its overall industry.

SBC Sales Forecast

Next quarter’s sales forecast for SBC is €170.33M with a range of €157.04M to €180.14M. The previous quarter’s sales results were €167.10M. SBC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year SBC has Performed in-line its overall industry.

SBC Stock Forecast FAQ

What is DE:SBC’s average 12-month price target, according to analysts?

Based on analyst ratings, Sabra Healthcare REIT’s 12-month average price target is 17.98.

What is DE:SBC’s upside potential, based on the analysts’ average price target?

Sabra Healthcare REIT has 6.12% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Sabra Healthcare REIT a Buy, Sell or Hold?

Sabra Healthcare REIT has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 5 hold ratings and 0 sell ratings.

What is Sabra Healthcare REIT’s share price target?

The average share price target for Sabra Healthcare REIT is 17.98. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €19.42 ,and the lowest forecast is €16.89. The average share price target represents 6.12% Increase from the current price of €16.94.

What do analysts say about Sabra Healthcare REIT?

Sabra Healthcare REIT’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of Sabra Healthcare REIT?

To buy shares of DE:SBC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Sabra Healthcare REIT (SBC) Stock Forecast & Price Target

SBC Analyst Ratings

SBC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sabra Healthcare REIT

SBC Analyst Recommendation Trends

SBC Financial Forecast

SBC Earnings Forecast

SBC Sales Forecast

SBC Stock Forecast FAQ

Detailed List of Analyst Forecasts